A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease
Public ClinicalTrials.gov record NCT05063539. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Assessment of Safety, Tolerability, and Efficacy of LY3372689 in Early Symptomatic Alzheimer's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the safety, tolerability and effect of study drug LY3372689 in participants with early symptomatic Alzheimer's Disease
Study identification
- NCT ID
- NCT05063539
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 327 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 60 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 16, 2021 (Actual)
- Primary completion
- Jul 9, 2024 (Actual)
- Completion
- May 22, 2025 (Actual)
- Last update posted
- Jun 12, 2026
2021 – 2025
United States locations
- U.S. sites
- 35
- U.S. states
- 11
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hope Clinical Research, Inc. | Canoga Park | California | 91303 | — |
| Neuro-Pain Medical Center | Fresno | California | 93710 | — |
| Irvine Clinical Research | Irvine | California | 92614 | — |
| Sharp Mesa Vista Hospital | San Diego | California | 92123 | — |
| Institute for Neurodegenerative Disorders | New Haven | Connecticut | 06510 | — |
| JEM Research Institute | Atlantis | Florida | 33462 | — |
| VIN-Julie Schwartzbard | Aventura | Florida | 33180 | — |
| Neurology Offices of South Florida | Boca Raton | Florida | 33428 | — |
| Brain Matters Research | Delray Beach | Florida | 33445 | — |
| Neuropsychiatric Research Center of Southwest Florida | Fort Myers | Florida | 33912 | — |
| K2 Medical Research | Maitland | Florida | 32751 | — |
| ClinCloud - Viera | Melbourne | Florida | 32940 | — |
| Merritt Island Medical Research, LLC | Merritt Island | Florida | 32952 | — |
| VIN-Andrew Lerman | Miami | Florida | 33133 | — |
| IMIC, Inc. | Miami | Florida | 33176 | — |
| VIN-Victor Faradji | Miami | Florida | 33176 | — |
| Suncoast Clinical Research, Inc. | New Port Richey | Florida | 34652 | — |
| Renstar Medical Research | Ocala | Florida | 34470 | — |
| VIN- Margarita Almeida El-Ramey | Pembroke Pines | Florida | 33026 | — |
| Brain Matters Research | Stuart | Florida | 34997 | — |
| Charter Research - Lady Lake | The Villages | Florida | 32162 | — |
| Josephson Wallack Munshower Neurology, PC | Indianapolis | Indiana | 46256 | — |
| Boston Center for Memory | Newton | Massachusetts | 02459 | — |
| Donald S. Marks M.D., P.C. | Plymouth | Massachusetts | 02360 | — |
| MedVadis Research Corporation | Waltham | Massachusetts | 02451 | — |
| Adams Clinical | Watertown | Massachusetts | 02472 | — |
| The Cognitive and Research Center of New Jersey | Springfield | New Jersey | 07081 | — |
| Advanced Memory Research Institute of New Jersey | Toms River | New Jersey | 08755 | — |
| University at Buffalo - UBMD Neurology | Buffalo | New York | 14203 | — |
| Abington Neurological Associates, Ltd. | Abington | Pennsylvania | 19001 | — |
| Keystone Clinical Studies | Plymouth Meeting | Pennsylvania | 19462 | — |
| Rhode Island Mood & Memory Research Institute | East Providence | Rhode Island | 02914 | — |
| Kerwin Medical Center | Dallas | Texas | 75231 | — |
| The University of Texas Health Science Center at Houston | Houston | Texas | 77054 | — |
| The Memory Clinic | Bennington | Vermont | 05201-9810 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05063539, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2026 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05063539 live on ClinicalTrials.gov.